๐ About
- ๐ Point-of-care test that measures viscoelastic properties of blood clotting
- โก Real-time assessment of hemostatic function from clot initiation to fibrinolysis
- ๐ฏ Provides comprehensive picture of coagulation cascade, platelet function, and clot stability
- ๐ฅ Increasingly used in surgery, trauma, and critical care settings
- โฑ๏ธ Results available in 5-30 minutes vs hours for traditional coagulation tests
๐ฌ Methodology
- ๐ฉธ Sample: Fresh whole blood (citrated or native)
- ๐ Principle: Measures resistance to shear as clot forms and dissolves
- ๐ Output: Real-time graphical trace showing clot development
- ๐ก๏ธ Temperature: Performed at 37ยฐC
- โ๏ธ Activators: Kaolin, tissue factor, or intrinsic pathway activators
๐ TEG Parameters & Normal Values
โฑ๏ธ R-Time (Reaction Time):
- ๐ฏ Normal range: 5-10 minutes
- ๐ Measures: Time to initial fibrin formation
- ๐ Prolonged R: Factor deficiency, anticoagulation, hypofibrinogenemia
- ๐ Shortened R: Hypercoagulable state
๐ K-Time & Alpha Angle:
- ๐ฏ K-Time normal: 1-3 minutes
- ๐ฏ Alpha angle normal: 53-72 degrees
- ๐ Measures: Rate of clot strengthening/fibrin polymerization
- ๐ Prolonged K/Low ฮฑ: Hypofibrinogenemia, thrombocytopenia
- ๐ Shortened K/High ฮฑ: Hyperfibrinogenemia
๐ช MA (Maximum Amplitude):
- ๐ฏ Normal range: 50-70 mm
- ๐ Measures: Maximum clot strength (platelets + fibrinogen)
- ๐ High MA: Thrombocytosis, hyperfibrinogenemia
- ๐ Low MA: Thrombocytopenia, platelet dysfunction, hypofibrinogenemia
๐ LY30 (Lysis at 30 minutes):
- ๐ฏ Normal range: 0-8%
- ๐ Measures: Fibrinolysis/clot breakdown
- ๐ High LY30 (>8%): Hyperfibrinolysis
- ๐ Low LY30: Impaired fibrinolysis
๐ฉบ Clinical Applications
๐ฅ Perioperative Management:
- ๐ช Cardiac surgery: Guide blood product transfusion
- ๐ซ Liver transplant: Monitor complex coagulopathy
- ๐ฆด Orthopedic surgery: Assess bleeding risk
- ๐ Anticoagulation reversal: Monitor effectiveness
๐จ Emergency & Trauma:
- ๐ฉธ Massive transfusion: Guide component therapy ratios
- ๐ Trauma coagulopathy: Early detection and management
- ๐ง Intracranial hemorrhage: Rapid coagulation assessment
- โก DIC diagnosis: Real-time coagulation monitoring
๐ฅ Critical Care:
- ๐ฆ Sepsis: Monitor coagulation changes
- ๐ซ ECMO patients: Anticoagulation monitoring
- ๐ Drug monitoring: Antiplatelet and anticoagulant effects
๐ฏ TEG-Guided Transfusion Algorithm
๐ Prolonged R-time (>10 min):
- ๐ Give: Fresh Frozen Plasma (FFP) 10-15 mL/kg
- ๐
ฐ๏ธ Alternative: Prothrombin Complex Concentrate (PCC)
- ๐ฏ Target: R-time 5-10 minutes
๐ Low Alpha angle (<53ยฐ) or prolonged K (>3 min):
- ๐งช Give: Cryoprecipitate 1-2 units/10kg
- ๐ฏ Target: Fibrinogen >1.5-2.0 g/L
- ๐ Alternative: Fibrinogen concentrate
๐ช Low MA (<50 mm):
- ๐ด Give: Platelets 1 unit/10kg (or 4-6 units adult)
- ๐ฏ Target: Platelet count >50 ร 10โน/L
- ๐ Consider: Desmopressin (DDAVP) if platelet dysfunction
๐ High LY30 (>8%):
- ๐ Give: Tranexamic acid 1g IV bolus
- โก Consider: Aminocaproic acid as alternative
- ๐ฏ Target: LY30 <8%
โ
Advantages of TEG
- โก Rapid results: Real-time monitoring vs hours for lab tests
- ๐ฏ Targeted therapy: Specific component deficiency identification
- ๐ฉธ Whole blood: Tests entire hemostatic system
- ๐ฐ Cost-effective: Reduced inappropriate transfusions
- ๐ Comprehensive: Covers coagulation, platelets, and fibrinolysis
- ๐ฅ Point-of-care: Bedside testing available
โ Limitations
- ๐จโโ๏ธ User-dependent: Requires training and experience
- ๐ฉธ Sample sensitive: Quality affects results
- ๐ฐ Equipment cost: Initial investment required
- โ๏ธ Standardization: Different machines may give varying results
- ๐ฌ Research needed: More studies needed in some clinical areas
- โ๏ธ Temperature sensitive: Hypothermia affects results
๐ Interpretation Examples
๐ฉธ Hemorrhagic Pattern:
- ๐ Prolonged R-time + Low MA = Factor deficiency + Thrombocytopenia
- ๐ Normal R + Low ฮฑ angle = Hypofibrinogenemia
- ๐ High LY30 = Hyperfibrinolysis
๐งฌ Hypercoagulable Pattern:
- ๐ Shortened R-time + High MA = Hypercoagulable state
- ๐ High ฮฑ angle = Hyperfibrinogenemia
- ๐ Low LY30 = Impaired fibrinolysis
๐ ROTEM vs TEG
- ๐ฌ ROTEM: Rotational thromboelastometry (European)
- ๐ TEG: Thromboelastography (American)
- โ๏ธ Similar principles: Both measure viscoelastic properties
- ๐ Different parameters: ROTEM uses CT, CFT, MCF vs R, K, MA
- ๐ฏ Clinical utility: Both guide blood product therapy
๐ References
- ๐ Society of Cardiovascular Anesthesiologists Guidelines
- ๐ฅ European Society of Anaesthesiology Guidelines
- ๐ Hemostasis and Thrombosis: Basic Principles
- ๐ฌ Journal of Thrombosis and Haemostasis
- ๐ American Society of Anesthesiologists Task Force
- ๐ฉธ Transfusion Medicine Reviews
๐ก KEY TAKEAWAY: TEG provides rapid, comprehensive assessment of hemostasis, enabling targeted blood product therapy and improved patient outcomes in bleeding scenarios